Trial Profile
A study on the efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infections.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections; Influenza B virus infections; Influenza virus infections
- Focus Therapeutic Use
- 22 Feb 2012 Status changed from not stated to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 11 Feb 2011 New trial record